Position in ZBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$40,451,123
+$16,090,789 QoQ
Shares Held
1,593,819
+27.9% QoQ
Ownership
2.45%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 145 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 90%
None 10%
Common Shares in ZBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. ZBIO ranks #52 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in ZBIO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,451,123 | 1,593,819 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,360,334 | 1,246,053 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $31,057,176 | 855,334 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $19,037,032 | 857,524 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,516,714 | 878,918 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,901,620 | 873,623 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,298,015 | 1,135,289 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $25,404,160 | 1,501,428 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||